Cargando…

Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder

BACKGROUND: Patients with opioid use disorder (OUD) have high hospital admission rates. Hospitalists, clinicians that work in inpatient medical settings, may have a unique opportunity to intervene on behalf of these patients, yet their experience with and attitudes towards treating patients with OUD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reed, Megan K, Murali, Vignesh, Sarpoulaki, Nazanin, Zavodnick, Jillian H., Hom, Jeffrey K., Rising, Kristin L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Full Length Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948932/ https://www.ncbi.nlm.nih.gov/pubmed/36844165 http://dx.doi.org/10.1016/j.dadr.2022.100106

Ejemplares similares

Perspectives of people in Philadelphia who use fentanyl/heroin adulterated with the animal tranquilizer xylazine; Making a case for xylazine test strips
por: Reed, Megan K., et al.
Publicado: (2022)

Psychiatric comorbidities and their treatment predict buprenorphine continuation among postpartum people with opioid use disorder
por: Shadowen, Hannah, et al.
Publicado: (2022)

Co-occurring psychiatric disorders and disparities in buprenorphine utilization in opioid use disorder: An analysis of insurance claims
por: Xu, Kevin Y, et al.
Publicado: (2023)

Buprenorphine involvement in opioid overdose deaths: A retrospective analysis of postmortem toxicology in Marion County, Indiana, 2015-2021
por: del Pozo, Brandon, et al.
Publicado: (2023)

Sex specific effects of buprenorphine on behavior, astrocytic opioid receptor expression and neuroinflammation after pediatric traumatic brain injury in mice
por: Hamood, Yesmine, et al.
Publicado: (2022)

Association of chronic non-cancer pain status and buprenorphine treatment retention among individuals with opioid use disorder: Results from electronic health record data
por: John, William S., et al.
Publicado: (2022)

Emergency-department initiated buprenorphine: Impact on quality of life
por: Carroll, Caleb, et al.
Publicado: (2023)

The introduction of a novel formulation of buprenorphine into organized health systems()()
por: Mullen, William, et al.
Publicado: (2022)

Patient-reported problems filling buprenorphine prescriptions and motivations for illicit use
por: Winstanley, Erin L., et al.
Publicado: (2022)

An observational study on the use of long acting buprenorphine (Sublocade) and a Tamper resistant PICC for Outpatient IV antibiotic administration in Patients with serious infections and Opioid Use Disorder; The STOP OUD project
por: Pineo, Thomas, et al.
Publicado: (2021)

Inpatient Buprenorphine Induction for Opioid Use Disorder in Pregnancy
por: Tavakoli, Amin, et al.
Publicado: (2023)

State alignment with federal regulations in 2022 to relax buprenorphine 30-patient waiver requirements
por: Silwal, Anita, et al.
Publicado: (2023)

Changes in buprenorphine visits in frontier and remote locations: Effects of the SARS-CoV-2 pandemic
por: McFadden, Lisa M.
Publicado: (2023)

Impact of COVID-19-related regulatory changes on nationwide access to buprenorphine: An interrupted time series design
por: Roy, Payel Jhoom, et al.
Publicado: (2023)

Receipt and duration of buprenorphine treatment during pregnancy and postpartum periods in a national privately-insured cohort
por: Wang, Xi, et al.
Publicado: (2023)

Differences in medicaid expansion effects on buprenorphine treatment utilization by county rurality and income: A pharmacy data claims analysis from 2009–2018
por: Golan, Olivia K., et al.
Publicado: (2023)

Prescription stimulant use during long-term opioid therapy and risk for opioid use disorder
por: Scherrer, Jeffrey F., et al.
Publicado: (2022)

Impact of reduced restrictions on buprenorphine prescribing during COVID-19 among patients in a community-based treatment program
por: Ward, Kathleen M., et al.
Publicado: (2022)

Synthesis, Radiosynthesis and Biological Evaluation of Buprenorphine‐Derived Phenylazocarboxamides as Novel μ‐Opioid Receptor Ligands
por: Krüll, Jasmin, et al.
Publicado: (2020)

Medicaid expansion and opioid supply policies to address the opioid overdose crisis
por: Shakya, Shishir, et al.
Publicado: (2022)

Inpatient Management of COVID-19 Pneumonia: a Practical Approach from the Hospitalist Perspective
por: Cutler, Todd S., et al.
Publicado: (2020)

Managing opioid withdrawal precipitated by buprenorphine with buprenorphine
por: Oakley, Bridget, et al.
Publicado: (2021)

Predictors of Dropout from Inpatient Opioid Detoxification with Buprenorphine: A Chart Review
por: Hakansson, Anders, et al.
Publicado: (2014)

Sustainment of contingency management within opioid treatment programs: COVID-related barriers and innovative workflow adaptations
por: Becker, Sara J., et al.
Publicado: (2021)

Peer recovery coaching for comprehensive HIV, hepatitis C, and opioid use disorder management: The CHORUS pilot study
por: Martin, Anna K., et al.
Publicado: (2023)

Factors Associated With Inpatient Subspecialty Consultation Patterns Among Pediatric Hospitalists
por: Kern-Goldberger, Andrew S., et al.
Publicado: (2023)

Assessing the feasibility, usability and acceptability of the MySafeRx platform among individuals in outpatient buprenorphine treatment: Lessons learned from a pilot randomized controlled trial
por: Janzow, Grace E., et al.
Publicado: (2022)

Inpatient Care of Patients with COVID-19: A Guide for Hospitalists
por: Yetmar, Zachary A., et al.
Publicado: (2020)

Identification and Evaluation of Novel Drug Targets against the Human Fungal Pathogen Aspergillus fumigatus with Elaboration on the Possible Role of RNA-Binding Protein
por: Malekzadeh, Saeid, et al.
Publicado: (2017)

Opioid treatment program prescribing of methadone with community pharmacy dispensing: Pilot study of feasibility and acceptability
por: Brooner, Robert K., et al.
Publicado: (2022)

Use of teledermatology by dermatology hospitalists is effective in the diagnosis and management of inpatient disease.
por: Gabel, Colleen K., et al.
Publicado: (2020)

Perspectives of Hospitalists in an Academic Health System
por: Clarke, TR, et al.
Publicado: (2022)

Co-creation of self-management support during inpatient stroke rehabilitation
por: Dobe, Joshua, et al.
Publicado: (2023)

Trends in opioid overdose fatalities in Cuyahoga County, Ohio: Multi-drug mixtures, the African-American community and carfentanil
por: Bhullar, Manreet K., et al.
Publicado: (2022)

Parenting and childcare responsibilities, harm reduction service engagement, and opioid overdose among women and men who use illicit opioids in New York City
por: Scheidell, Joy D, et al.
Publicado: (2022)

Serum Antibodies against Helicobacter pylori Neutrophil Activating Protein in Carriers of IL-4 C-590T Genetic Polymorphism Amplify the Risk of Gastritis and Gastric Cancer
por: Talebkhan, Yeganeh, et al.
Publicado: (2017)

A case study for local data surveillance in opioid overdose fatalities in Cuyahoga County, OH 2016-2020
por: Noriega, Ivette, et al.
Publicado: (2023)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
por: Ziaaddini, Hassan, et al.
Publicado: (2018)

Under-representation of key demographic groups in opioid use disorder trials
por: Rudolph, Kara E., et al.
Publicado: (2022)

COVID-19 impact on opioid overdose after jail release in Massachusetts
por: Friedmann, Peter D., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uu2ks0bv6ueq3ufvts5lbfic3e